SPL 1.60% 9.6¢ starpharma holdings limited

ASCO 22 and Starpharma, page-4

  1. 3,351 Posts.
    lightbulb Created with Sketch. 793
    Starpharma do not need more secret partner 6 year pre-clinical research agreements. Well Jackie Fairley might like them because it keeps the KPIs and bonuses ticking over but it does sweet FA for shareholders.

    Rubber on the road licencing agreements do not occur from ‘networking’ at ASCO. So let’s put that to bed. Nice desperate attempt at a pump though…
    Last edited by sarge17: 03/06/22
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.6¢
Change
0.002(1.60%)
Mkt cap ! $39.38M
Open High Low Value Volume
9.4¢ 9.6¢ 9.4¢ $32.09K 339.3K

Buyers (Bids)

No. Vol. Price($)
1 3699 9.5¢
 

Sellers (Offers)

Price($) Vol. No.
9.8¢ 65000 1
View Market Depth
Last trade - 13.54pm 06/08/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.